Nucleosome assembly proteins have been identified in all eukaryotic species investigated to date and their suggested roles include histone shuttle, histone acceptor during transcriptional chromatin remodelling and cell cycle regulator. To examine the role of these proteins during early development we have isolated the cDNA encoding Xenopus NAP1L, raised an antibody against recombinant xNAP1L and examined the expression pattern of this mRNA and protein. Expression in adults is predominantly in ovaries. This maternal protein remains a major component of xNAP1L within the embryo until swimming tadpole stages. xNAP1L mRNA is initially throughout the embryo but by gastrula stages it is predominantly in the presumptive ectoderm. Later, mRNA is detected in the neural crest, neural tube, eyes, tailbud and ventral blood islands. In order to test whether xNAP1L has a potential role in gene regulation we overexpressed this protein in animal pole explants and tested the effect on expression of a series of potential target genes. The mRNA encoding the transcription factor GATA-2 was markedly up-regulated by this overexpression. These data support a role for xNAP1L in tissue-restricted gene regulation. q
Introduction
Chromatin structure is now known to have a role in the regulation of gene expression and other key cellular processes; the biochemical basis of chromatin disruption has therefore been analysed extensively (Orphanides and Reinberg, 2002; Wolffe and Hayes, 1999 and references therein). These analyses have lead to the identification of a number of core-histone binding proteins that may be involved in forming and disrupting nucleosomes (Ito et al., 1997) including the nucleosome assembly proteins (NAPs) (Ishimi et al., 1983 (Ishimi et al., , 1984 . Members of the NAP family have limited sequence homology (Ishimi and Kikuchi, 1991; Kato, 1990; Simon et al., 1994; Ito et al., 1996; Watanabe et al., 1996; Rodriguez et al., 1997) and share the ability to assemble histones into nucleosomes on DNA templates in vitro, although the nucleosomes formed appear abnormal (Ito et al., 1996) . As expected for a protein with this activity, yeast NAP1 (yNAP1) binds to histones in vitro (McQuibban et al., 1998) . Immunoprecipitation experiments have also shown that human NAP1 (hNAP1L) and Drosophila NAP1 (dNAP1) bind principally to H2A and H2B in crude cell extracts (and so most likely in vivo) (Ito et al., 1996; Chang et al., 1997) . That these interactions take place with the histone tails has been shown for murine NAPs (Shikama et al., 2000) . Further clues for potential roles of the NAP family proteins come from their distribution in vivo.
Whilst human NAP1L and dNAP1 are found widely distributed in adults and embryos, respectively, there is evidence that some members of the NAP family do have tissue-specific expression patterns; in particular some are found specifically in the brain (Kato, 1990; Fan et al., 1998) . At the sub-cellular level, the human NAP family member HB20 is found in cell nuclei (Fan et al., 1998) whereas yNAP1 is predominantly cytoplasmic , making it unlikely that its sole function is as a chromatin assembly factor. Recent evidence shows that, in yeast, NAP1 acts to mediate the interaction between H2A and H2B and their importin/karyopherin and that it is necessary for the correct nuclear import of these histones (Mosammaparast et al., 2002) . In Drosophila, NAP1 is part of a complex, ACF, which is capable of producing correctly spaced nucleosomal arrays on DNA in vitro (Ito et al., 1996) . During the cell cycle, dNAP1 is nuclear during S-phase and cytoplasmic during G2 suggesting that it may also be a histone shuttle; involved in the transport of histones across the nuclear membrane (Ito et al., 1996) . Human NAP1L4 (also called hNAP2) is also nuclear during S-phase and cytoplasmic during G0/G1, mimicking the Drosophila results, and suggesting that this may be the major histone shuttle in human cells (Rodriguez et al., 1997) . Related to the cell cycle, both yNAP1 and a Xenopus NAP1 have been shown to interact specifically with B-type cyclins and to be phosphorylated by cyclin B/p34 cdc2 in vitro . Deletion of the NAP1 gene in yeast showed that it is required for the proper function of Clb2 and regulates cell cycle in combination with the Gin4 kinase (Altman and Kellogg, 1997) . Human NAP1L may also have a role in regulating cell proliferation; reduction of its levels by antisense RNA in T-cells resulted in their decreased proliferation in response to mitogenic stimulation (Simon et al., 1994) . Thus, some NAP proteins have a role in the cell cycle and may have their sub-cellular location regulated during cell division, acting as histone shuttles.
Another potential role for the NAP proteins is revealed by the observation that, in vitro, yNAP1 and nucleoplasmin can stimulate transcription factor binding to nucleosome cores in a process that requires displacement of the histone octamer (Walter et al., 1995) . More recent evidence also suggests a role for NAP in transcriptional regulation via its interaction with the co-activator p300/CBP (Ito et al., 2000; Shikama et al., 2000; Asahara et al., 2002) . Human and murine NAP1 and NAP2 can interact with p300 and act to augment p300 dependent transcription (Shikama et al., 2000) .
The in vivo functions of the NAP proteins may remain somewhat unclear, but their involvement in cell cycle regulation and potential role in transcription control imply they have a role in development. Confirming this, a role for mNAP1L2 (which is expressed in post-mitotic neurons) in the control of neural development was made clear by gene disruption experiments in mice. Whilst death of these mice occurred from mid-gestation onwards, surviving chimeric mice showed extensive surface ectoderm defects, open neural tubes and exposed brains (Rogner et al., 2000) . This strongly suggests a tissue-specific role for mNAP1L2 in neuron proliferation regulation. Also supporting a key role for NAPs, knockout of Drosophila NAP1 is embryonic lethal (Lankenau et al., 2003) . To investigate the role of NAP proteins in development further, we isolated a cDNA encoding the Xenopus orthologue of hNAP1L1 and commenced a series of experiments to test its developmental role. Xenopus versions of the NAP proteins have been reported previously but work has concentrated on their role in the cell cycle rather than development per se. Here we show that Xenopus NAP1L, by sequence analysis an orthologue of mammalian NAP1L1 proteins, is a maternal mRNA and cytoplasmic phosphoprotein. In embryos, xNAP1L is detected in both the cytoplasm and nucleus and its total levels remain constant during embryonic development to the swimming tadpole stage. The zygotic mRNA and protein are expressed in a more tissue-restricted manner, appearing in the brain, eyes, branchial arches and ventral blood islands (v.b.i.) . Overexpression of the protein in embryo explants leads to up-regulation of the steady state levels of GATA-2 mRNA, a gene transcribed in the v.b.i., whilst leaving other genes unaffected. Together these data suggest that xNAP1L can have a role in gene regulation and that this role is restricted to particular cell types in the developing embryo.
Results

xNAP1L has high sequence identity to other vertebrate NAP1Ls
Isolation of cDNAs encoding NAP related proteins from a gastrula stage cDNA library produced several identical 1.4 kb cDNAs predicted to encode the open reading frame of a protein highly related to mammalian NAP1L1s. The predicted Xenopus NAP1L protein is 92% identical to those of humans and mice ( Fig. 1(A) ). It includes predicted nuclear localisation signals (Robbins et al., 1991; Cokol et al., 2000, residues 83 -89; 264 -289) , a possible PEST domain (Rogers et al., 1986, residues 338 -380) and numerous potential phosphorylation sites. This protein is, however, significantly different from other vertebrate NAP family members (maximum 60% identity) and from those of non-vertebrate species. Maximum likelihood analysis clearly shows the vertebrate NAP1L sequences forming a strongly supported clade (100% support), distinct from non-vertebrate and plant proteins ( Fig. 1(B) ). Within this clade, mammalian NAP1Ls separate into another strongly supported clade (95% support) from those representing Xenopus (Fig. 1(A) ). The divergence patterns revealed by the cladogram (Fig. 1(B) ) suggest that the NAP1L protein may be putatively orthologous in the different lineages, although the exact position of non-vertebrate NAP1L sequences remains unresolved.
2.2. xNAP1L mRNA is predominantly in oocytes in adults but remains at constant levels throughout early embryonic development
In order to discover whether xNAP1L was expressed at similar levels throughout all adult tissues, Northern blotting was carried out. RNA prepared from equal weights of a range of tissues was probed for xNAP1L and then for the translation elongation factor EF-1a (Krieg et al., 1989 ) as a control for loading ( Fig. 2(A) ). The signals were quantified by phosphorimager and xNAP1L levels normalised to those of EF-1a. A single mRNA species of 1.6 kb was detected in most tissues analysed, albeit at very similar low levels. The exception was ovary which contained some 20-fold more xNAP1L mRNA than any other tissue. The predominance of the mRNA in ovarian tissue prompted the analysis of xNAP1L mRNA levels during embryonic development. Northern blotting again revealed a single transcript of 1.6 kb and Xenopus laevis were aligned using the Gonnet matrix implemented in CLUSTAL W with a gap-opening penalty of 35 and a gap-extension penalty of 0.75. The alignment was imported into GENEDOC. The amino acid residues highlighted in black are conserved, and partially conserved regions are shown in grey. (B) Cladogram representing the relationship between NAP1L sequences from vertebrates, invertebrates, plant and fungi estimated under maximum likelihood criteria. The frequencies of amino acids were estimated from a dataset of 401 residues and modelled using VT substitution matrix (Müller and Vingron, 2000) with rate heterogeneity described by an estimated gamma distribution of eight classes. The tree topology was resolved by quartet puzzling involving 3000 steps. Values given above the branches are the quartet puzzling supports.
that was present at essentially constant levels in blastula, gastrula and neurula embryos but increased at swimming tadpole stages ( Fig. 2(B) ).
xNAP1L mRNA expression becomes tissue-restricted as development progresses
In order to test whether xNAP1L mRNA was distributed evenly throughout the zygote, xNAP1L mRNA in blastula, gastrula, neurula, tailbud and swimming tadpole embryos was analysed by in situ hybridisation. At blastula stages, xNAP1L mRNA was detected predominantly in the animal pole ( Fig. 3 (B) and (C)) and at the highest concentrations perinuclearly (arrowed in Fig. 3(C) ). Since the high levels of yolk in the vegetal pole of Xenopus embryos have been known to mask in situ hybridisation signals we tested the levels of xNAP1L mRNA by an independent method. Eightcell embryos were dissected into vegetal pole and dorsal (as defined by small light blastomeres) and ventral animal pole halves. Northern analysis of RNA from these dissected regions showed that xNAP1L mRNA was present throughout the eight-cell embryo but at higher levels in the animal than vegetal pole (data not shown). At the start of gastrulation, xNAP1L mRNA is detectable in the ectoderm and involuting mesoderm ( Fig. 3 (E) and (F); the dorsal lip is arrowed in Fig. 3(F) ) whilst at stage 18 the expression is mainly in the anterior neural plate and the region immediately posterior to the cement gland ( Fig. 3(G) ). This region continues expressing xNAP1L mRNA in late neurula/early tailbud stages when the eyes, branchial arches and neural tube are all stained, as is the tip of the growing tail ( Fig. 3 (H) and (I)). A section through the head shows that expression is mainly in the ectoderm (this is a bleached embryo) although detectable in the branchial arches and lens ( Fig. 3(J) ). xNAP1L mRNA first becomes visible in the characteristic Y-shaped pattern of the v.b.i. at this stage, where expression increases in the hatched embryo (arrowed in Fig. 3(K) ). However, double staining with globin (turquoise) and xNAP1L (purple) probes revealed that xNAP1L mRNA was found in the ectoderm precisely overlying the v.b.i. and only in the outer cells of the haematopoietic mesoderm ( Fig. 3(L) ).
xNAP1L protein is phosphorylated, detectable throughout oogenesis and remains at constant levels during early development
Previous studies have shown that, for mRNAs expressed maternally, protein and mRNA expression patterns are not necessarily coincident (Veenstra et al., 1995; Orford et al., 1998) presumably due to the persistence of maternally derived protein. Since the tissue-restricted expression of xNAP1L mRNA was unexpected given its suggested functions, an antibody to the protein was raised and used to analyse xNAP1L protein expression in oocytes and embryos by Western blotting and immunohistochemistry. The antibody specifically recognises a doublet of proteins of apparent molecular weights 50 and 54 kDa on SDS-PAGE (Fig. 4(A) ), which were confirmed as NAP by sequential immunoprecipitation and Western blotting using our newly raised antibody and a monoclonal antibody that recognises all NAP proteins (Ishimi et al., 1984; data not shown) . This observed mobility is considerably lower than its calculated molecular weight of 45 kDa, similar to the situation observed for dNAP1, hNAP1L and hNAP2 (Ito et al., 1996; Rodriguez et al., 1997) . Drosophila NAP has been shown to be a phosphoprotein (Li et al., 1999) and immunoprecipitation of xNAP1L from oocytes labelled with 32 P orthophosphate confirms that this is also the case in Xenopus (Fig. 4(B) ). Analysis of xNAP1L protein levels during oogenesis showed that the protein was detectable in a mixed sample of stage 1 and 2 oocytes, xNAP1L then accumulated steadily up to stage 5 (Fig. 4(A) ). Manual dissection of oocytes into nuclear (germinal vesicle), cytoplasmic, animal and vegetal fractions followed by Western analysis of the dissected material revealed that xNAP1L is a cytoplasmic protein, the distribution of which is biased towards the animal half of the oocyte (Fig. 4(C) ). As a control for the accuracy of dissections, CBTF 122 levels were analysed in the same samples, this protein is nuclear in oocytes and therefore restricted to the animal hemisphere (Orford et al., 1998) . During embryonic development, total xNAP1L levels remained essentially constant up to the swimming tadpole stage, the latest tested (Fig. 4(D) ). (B) Two-hundred stage VI oocytes were incubated for 8 h at 21 8C in MBS (400 ml) containing 0.5 mCi 32 P orthophosphate. Protein prepared from the radiolabelled oocytes was immunoprecipitated with antiserum raised either against xNAP1L or an unrelated protein as control. Immunoprecipitated proteins were separated by SDS-PAGE and phosphoproteins visualised by autoradiography. (C) Defolliculated stage VI oocytes were manually dissected into germinal vesicle and enucleated fractions or animal and vegetal explants. Protein was prepared from sets of 15 explants or fractions and yolk removed. Protein equivalent to one explant was separated on duplicate SDS-PAGE gels and xNAP1L or p122 were visualised by Western blotting. (D) Embryos were staged and collected in sets of 15, protein was prepared from each set and yolk removed. Proteins equivalent to one embryo were separated by SDS-PAGE and xNAP1L detected by Western blotting. In all cases integrity of the protein and equivalence of loading was checked by Coomassie straining of duplicate gels.
xNAP1L protein becomes nuclear and progressively tissue-restricted during development
Although the levels of xNAP1L remained constant, it has been shown for maternal factors regulating transcription that a movement from the nucleus to the cytoplasm occurs during early development, most often at the MBT (Miller et al., 1991; Orford et al., 1998) . Immunohistochemistry of sections of stage 6 embryos show that endogenous xNAP1L is in the cytoplasm (Fig. 5(B) ) whilst by stage 10 the protein is also nuclear in many cells (Fig. 5(D) and (E), examples arrowed). In order to visualise this translocation more clearly, synthetic mRNA encoding hemaglutanin-tagged xNAP1L was injected into embryos and the protein detected using an antibody recognising the epitope tag ( Fig. 5(F) and (G)). Again the protein was cytoplasmic prior to the MBT (an unstained nucleus is arrowed in Fig. 5(F) ) but predominantly nuclear subsequently. By the time the embryos reach swimming tadpole stages the contribution of the maternal protein is probably beginning to diminish since the staining pattern relates much more to that observed for the mRNA, for example, in the branchial arches ( Fig. 5(I) ).
Overexpression of xNAP1L increases GATA-2 expression in animal pole explants
Since the expression of xNAP1L was tissue-restricted and there is evidence of a role for this protein in transcription regulation it was decided to test whether overexpression of xNAP1L could control the expression of specific genes. xNAP1L is expressed in the ectoderm precisely overlying the v.b.i. and the outer globin-expressing cells (Fig. 3(L) ) and it has been shown that ectodermal signals are necessary for globin expression (Maeno et al., 1994) . This lead us to test whether the expression of two genes thought to be involved in this signalling process, BMP-4 and GATA-2 (Maeno et al., 1996) , was altered by xNAP1L overexpression. Since this signalling is based in the ectoderm, animal pole explants were removed from mRNA-injected embryos and the steady-state levels of a number of transcripts measured by reverse transcriptasepolymerase chain reaction (RT-PCR). The ubiquitously expressed genes, histone H4 and ornithine decarboxylase were unaffected by xNAP1L overexpression and epidermal keratin levels were unchanged, showing that the animal pole tissue remained epidermal. BMP-4 expression was slightly elevated at both xNAP1L RNA concentrations tested and GATA-2 mRNA was greatly increased, but only at the higher concentration of injected RNA (Fig. 6) . A number of other genes (for example, wnt8, brachyury and chordin) were also unaffected and the altered gene expression was only seen when sibling embryos had developed to swimming tadpole stages (data not shown).
Discussion
The NAP protein family
Xenopus NAP1L is highly related to the vertebrate NAP1L1 proteins but quite distinct from other vertebrate NAPs and those of non-vertebrate species. Many putative functional domains of these proteins are, however, conserved more widely, for example, nuclear localisation signals and PEST domains. Whilst there is evidence for the involvement of several NAPs in histone transport and deposition, this does not apply to the vertebrate NAP1L1 clade identified here and it is likely that, at least in vertebrates, the diverged NAP proteins have a number of distinct functions.
Expression patterns of NAP mRNAs
The finding that xNAP1L mRNA was detectable in all adult tissues tested, but at much higher levels in the ovaries, suggested that xNAP1L has a prominent role during early development. hNAP1L1 (Simon et al., 1994) , was similarly detected at a consistently low level in all adult tissues investigated, but germ cells were not tested. It was also shown that hNAP1L1 expression was higher in carcinoma tissues and cell lines. Three isoforms of rat NAP1 mRNA were present at low levels in all adult tissues, whilst similar levels of two of the isoforms were found in neo-natal tissues (Cataldo et al., 1999) . Enriched amounts of rNAP1 were present in haematopoietic tissues and this may relate to our observations for xNAP1L (below). hNAP2L transcripts were found at similar levels in a range of adult and foetal tissues, but expression was 3-fold higher in the testis (Hu et al., 1996) . Whilst this observation is similar to that for xNAP1L, no increase was seen in ovarian tissue and thus it appears that different NAP proteins have distinct but overlapping expression domains.
The data presented here suggest that one of the major sites of xNAP1L expression during development is the neural tissue. This is similar to rat NAP1, which is also expressed at enhanced levels in the brain (Cataldo et al., 1999) . The brain-specific NAP identified in human and mouse (Rougeulle and Avner, 1996) , NAP1L4, is first detected in mouse embryos at neurula stages (Rogner et al., 2000) , which is different from xNAP1L, a maternal mRNA. Using in situ hybridisation on sections, these authors suggested that NAP1L4 was most strongly expressed in post-mitotic neurons on the basis of greater intensity of signal in differentiated tissue. Further experiments will be needed to test whether a similar situation exists in Xenopus.
The expression pattern of xNAP1L mRNA revealed here is very similar but not identical to that found previously during the expression screening studies that led to the definition of synexpression groups (Gawantka et al., 1998) . One cDNA, placed in the chromatin synexpression group, was identified as NAP1 by comparison with mNAP1 in Fig. 5 . xNAP1L is cytoplasmic prior to the MBT but enters nuclei subsequently. (A-F) Embryo sections were used for immunohistochemistry with either a preimmune serum (A, C and E) or the anti-xNAP1L serum (B, D, F and G) . (A-D) show sections from stage 6 embryo blastomeres and staining is visible throughout the cells except for the nuclei (upper panels) which are highlighted by DAPI staining (lower panels). (E-F) show sections through gastrula stage embryos, staining is strongest in the ectodermal and mesodermal cells but also seen in the endoderm. In all layers there is now nuclear staining (examples are arrowed in (F)) coincident with DAPI fluorescence (G). (H and I) Embryos were injected at the two cell stage with 100 pg of synthetic RNA encoding hemaglutanin-tagged xNAP1L and allowed to develop until stage 7(H) or 9(I). They were then fixed and the exogenous protein was detected by immunohistochemistry. In the stage 7 embryos staining is absent from nuclei (arrowed in (G)) but by stage 9 punctuate staining of nuclei is seen, although there is still substantial signal in the cytoplasm. a BLAST search. The fragment used was 359 nucleotides in length and identical to nucleotides 1107 -1466 of xNAP1L (with one gap). Members of the chromatin group were strongly expressed at neurula stages, and expression levels dropped or disappeared in certain tissues by stage 30. xNAP1L exhibits continued expression well beyond these stages, particularly in specific tissues of the stage 38 embryo, together with an increasing signal in the v.b.i and the region of the dorsal lateral plate. This may suggest that it has additional roles compared to other members of the group or alternatively simply reflect the limited data that can reasonably be obtained for the large gene numbers needed in a widespread screen.
The striking correlation between xNAP1L and globin mRNA expression suggests that xNAP1L has some role in embryonic blood formation. xNAP1L is mainly ectodermal, and zygotic signals from the ectoderm have been shown to be necessary for globin expression in explant experiments (Maeno et al., 1994) . BMP-4 and 7 have been proposed as candidate signalling molecules in this process, acting in conjunction with the transcription factor GATA-2 (Maeno et al., 1996) . It has been shown that the requirement for BMP signalling for globin expression occurs, at the earliest, late in gastrulation (Kumano et al., 1999) . Like GATA-2, xNAP1L mRNA has a strong ectodermal presence at gastrula stages and GATA-2 is expressed in the same region as xNAP1L, overlying the blood islands, later in development (Walmsley et al., 1994) . The ability of xNAP1L to alter GATA-2 mRNA levels suggests that it too may have some involvement in the ectoderm to v.b.i.-signalling process. In a similar context, Cataldo et al. (1999) found increased levels of rat NAP1 in haematopoietic tissues, and up-regulation of the transcript in tissues cultured with megakaryocytopoietic ligand (Mpl), which has been shown to induce globin expression in Xenopus embryo explants (Kakeda et al., 2002) .
xNAP1L protein expression
The levels of total xNAP1L mRNA and protein are essentially constant during embryonic development and it is not until swimming tadpole stages that protein can be detected at enhanced levels in the regions containing zygotic xNAP1L mRNA. At earlier stages, both the protein and mRNA are preferentially distributed in the animal pole and the cells derived from it. These facts suggest that maternally derived xNAP1L is persistent, as previously observed for Oct-1 and CBTF 122 (Veenstra et al., 1995; Orford et al., 1998) . The two proteins of similar size detected throughout development may reflect differentially modified forms of xNAP1L or the products of pseudoalleles found in Xenopus laevis, which is allotetraploid (Bisbee et al., 1977) . We tested the latter by carrying out Western blotting of xNAP1L on extracts from Xenopus tropicalis embryos. This diploid Xenopus species also has the two forms of the protein (data not shown), strongly suggesting that these result from differential modification. This hypothesis is supported by the fact that immunoprecipitation of xNAP1L labelled with 32 P reveals only a single specific band and that multiply charged forms of the larger band are found when extracts are analysed by 2D electrophoresis and Western blotting (AA, unpublished data). Other members of the NAP family have been reported to be phosphorylated and also polyglutamylated (Li et al., 1999) .
The sub-cellular distribution of xNAP1L in oocytes is different from that of a well-characterised Xenopus histone shuttle, nucleoplasmin, which is present in the germinal vesicle (Litvin and King, 1988) . Similarly, nucleoplasmin is in nuclei during early embryonic development (Litvin and King, 1988) whereas xNAP1L is cytoplasmic at cleavage stages, however, both of these proteins are predominantly found at the animal pole. In embryos, the movement of the bulk of xNAP1L from the cytoplasm to the nucleus occurs close to the midblastula transition, this is coincident with a number of nuclear events including zygotic gene activation and the ability of transcriptional co-activators to function (Veenstra et al., 1999) . The latter may be significant since there is evidence that mammalian NAP proteins are involved in the co-activation process (Shikama et al., 2000) . 
NAP function during early development
The expression pattern of xNAP1L suggests that it may have a role in tissue-restricted nuclear events, potentially including gene regulation. The data presented here suggest that, at least in the context of overexpression in an explant, xNAP1L can affect mRNA levels of a specific gene, GATA-2. Since the expression of xNAP1L and the target that we have identified are at least partially coincident in vivo, it is possible that this observation reflects a regulatory situation occurring in the embryo.
In summary, xNAP1L is a maternal mRNA and protein that is cytoplasmic until the MBT when it is found in both nuclei and the cytoplasm. Initially the mRNA and protein are at their highest levels in the ectoderm but become more tissue-restricted during development. xNAP1L expression is remarkably coincident with haematopoietic tissue and overexpression of xNAP1L up-regulates the level of GATA-2 mRNA-a gene essential for haematopoiesis (Tsai et al., 1994) . Much of the literature suggests that NAPs act simply as histone shuttles and, whilst the data presented here do not exclude this possibility for xNAP1L, it is unlikely since there is little correlation between regions of high NAP expression and increased levels of cell division (Saka and Smith, 2001) . The data obtained are more supportive of a role for this protein in tissue-restricted gene regulation, most likely in several tissues including blood.
Experimental procedures
Isolation and sequencing of xNAP1L cDNA
A stage 10 X. laevis animal cap cDNA library (a gift from Jim Smith and Alison Snape) was probed with a human HMGIC cDNA probe at low stringency in an attempt to isolate the Xenopus version of that gene (Sambrook et al., 1989) . A number of cDNAs were isolated and one was identified as xNAP1L. Overlapping cDNAs corresponding to the complete open reading frame of this protein were then isolated and standard DNA manipulation methods were used to produce a single cDNA. The cDNA was divided into shorter regions, propagated, and the sequence of the resulting plasmid inserts determined by a combination of manual (Sequenase kit) and automated (Cambio) methods. Sequences on both strands obtained throughout the cDNA were aligned using Genejockey II and the predicted open reading frame was also produced using this program.
Phylogenetic analysis
NAP1L sequences were aligned using CLUSTAL W (Thompson et al., 1994) with the Gonnet matrix, a gapopening penalty of 35.0 and a gap extension penalty of 0.75. The alignment was manually adjusted in GENEDOC to generate a data matrix comprising taxa, Mus musculus (BAA02142.1), Rattus norvegicus (AAC67388), Homo sapiens (AAC37544.1), X. laevis (the protein described here), Drosophila melanogaster (NP477128.1), Hemicentrotus pulcherrimus (BAA04884.1), Anisakis simplex (CAB58173.1), Glycine max (AAA88792.1), Pisum sativum (AAB72115.1), Arabidopsis thaliana (AAK43864.1 and BAA97025.1), Schizosaccharomyces pombe (T41330) and Saccharomyces cerevisiae (S38122). Maximum likelihood analyses, implemented in TREE-PUZZLE 5.0 von Haeseler, 1996, 1997; , were performed using complete (401 amino acid residues) and unambiguously aligned (299 amino acid residues) matrices. Substitution models used to construct distance matrices included WAG (Whelan and Goldman, 2001 ) and VT (Müller and Vingron, 2000) using an estimated gamma distribution to model rate heterogeneity. Trees were constructed using the neighbour-joining method of TREE-PUZZLE 5.0. Support for each node was estimated using the quartet puzzling values derived from 3000 puzzling steps. Only a small proportion of unresolved quartets (, 2 -4%) were detected in each analysis and similar topologies were recovered from each matrix. In all analyses S. cerevisiae was used as the out-group.
Northern blotting and in situ hybridisation
Oocytes and embryos were prepared and cultured as previously described (Guille, 1999) ; they were staged according to Dumont (1972) and Nieuwkoop and Faber (1967) , respectively. Tissues were dissected from adult frogs and RNA prepared using Trizol (Gibco-BRL) following the manufacturer's instructions. Northern blotting was carried out using the method of Hopwood et al. (1989) ; approximately 10 mg of total RNA corresponding to equal weights of tissue or two embryos was loaded in each lane and the blots were probed with a 1173 bp Xba I to Pst I fragment from xNAP1L. The final stringency washes were at 64 8C in 0.1 £ SSPE, 0.1% SDS. Whole-mount in situ hybridisation was performed as described previously (Broadbent and Read, 1999) . Thick sections of wholemount embryos were prepared as described (Broadbent and Read, 1999) . The same xNAP1L probe was used for in situ hybridisation on sections as described by Ciau-Uitz et al. (2000) . Whole-mount embryos were photographed using a Nikon FDX.35 camera mounted on a Nikon SMZ-U dissecting microscope and sections were visualised using DIC optics on a Nikon E800 eclipse microscope.
Preparation and characterisation of antiserum
xNAP1L cDNA was amplified from plasmid by PCR using primers corresponding to the open reading frame and introducing an Nhe I site before the initiation codon and an Xho I site at the terminator. The PCR product was cleaved with these enzymes and then ligated into the corresponding sites in pET28b (Novagen). In order to produce truncated protein for use as an immunogen a stop codon was inserted into the BamH I site in the xNAP1L reading frame at position 163; the resulting protein lacks the sequences of amino acids that are highly conserved between members of the NAP family. The sequence of the resulting plasmid insert was checked prior to further use. Histidine-tagged protein was produced in E. coli strain BL21(DE3)pLysS, the cells lysed by sonication and the protein purified on a nickel column according to the manufacturer's instructions (Novagen). To remove the His tag with the recombinant protein immobilised on the column, five volumes of thrombin cleavage buffer (20 mM Tris -HCl, pH 8.4, 0.15 M NaCl, 2.5 mM CaCl 2 ) were washed through. Cleavage was for 2 h at room temperature with 6 units of thrombin having been run into the column in one volume of cleavage buffer. The column was returned to 4 8C, washed with six volumes of Novagen elution buffer and the fractions analysed by SDS-PAGE. Two milligrams aliquots of purified protein were lyophilised and subsequently used to immunise a sheep (Diagnostics Scotland). The sheep serum was characterised by Elisa and Western blotting using standard techniques against recombinant xNAP1L prepared as above. Reactive sera were then tested further against NAP protein fractions immunoprecipitated from Xenopus oocytes and embryos using a monoclonal antipan NAP antibody (Prof. Ishimi, Mitsubishi Kasei Institute, Tokyo).
Immunohistochemistry
To observe endogenous xNAP1L, embryos were fixed in buffered picric acid -formaldehyde (Stefanini et al., 1967) , embedded in PEDS wax and cut into 10 mm sections on a Leica RM2165 microtome. De-waxed sections were blocked for 30 min with PBT plus 10% non-immune, heat-inactivated donkey serum. The block was replaced with a 1:250 dilution of the pre-immune or anti-xNAP1L serum in the same buffer and incubated for 1 h. Three and five minute washes in PBT were followed by a 1-h incubation with donkey anti-sheep HRP-conjugated antibody (1:1000). Three final washes in PBT preceded colour development with Fast-DAB (Sigma). To express the exogenous, hemaglutanin-tagged xNAP1L, embryos at the two cell stage were injected with 100 pg of the appropriate synthetic RNA and allowed to develop to the stages shown. The exogenous protein was then immunostained using an anti-hemaglutanin antibody as described (Robinson and Guille, 1999) .
4.6. Overexpression of xNAP1L in animal pole explants xNAP1L from bluescript was amplified by PCR using primers corresponding to the open reading frame and introducing an Xba I site before the initiation codon and an Xho I site at the terminator. The PCR product was cleaved with these enzymes and then ligated into the corresponding sites in pBUT2Sfi (Brzostowski et al., 2000) . Synthetic xNAP1L mRNA was prepared by linearisation of the above plasmid using Sfi I and subsequent transcription using a mMessage machine kit (Ambion). The mRNA was injected into the animal pole of both cells of two-cell embryos and these were allowed to develop until stage 8 when the animal poles were explanted and cultured (Green, 1999) . The levels of mRNAs in the explants were analysed by RT-PCR as described previously (Steinbach and Rupp, 1999) .
